AbbVie's publication of clinical data helps physicians, patients and healthcare providers make informed treatment decisions. Using this data, researchers can more easily build on our research and the research of others to drive scientific progress forward. The publication of the data fulfils the requirements of Articles 71-73 of the Therapeutic Products Ordinance (TPO). This applies to all products that have been authorised by Swissmedic since January 2020.
Product list, alphabetical, sorted by active ingredient
The AbbVie webpage you have requested is only intended for certain countries. (You will find the relevant information on the page.) Therefore, the website may contain information on medicinal products, other products or uses of these products that are not authorised in other countries or regions. If the latter applies to you, please contact your AbbVie national subsidiary to obtain the correct product information for your country. The AbbVie webpage you have requested is not in German. The AbbVie webpage you have requested may not be optimised for your screen size. Would you like to continue?